Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4318 (MIR4318, hsa-mir-4318) is a small, non-coding RNA molecule classified as a human microRNA. Like other microRNAs, MIR4318 functions by binding to target messenger RNA (mRNA) sequences, typically resulting in gene silencing through translational repression or mRNA degradation[1][2][5]. These molecules are crucial regulators of gene expression and are involved in multiple cellular processes such as cell proliferation, apoptosis, and development[1][2][5]. MIR4318 has been identified in comprehensive microRNA profiling studies and, according to pathway and biomarker analysis, may be functionally associated with the development and progression of certain cancers, particularly colorectal cancer, and gastrointestinal disease[3]. However, as of now, there are no approved drugs known to interact directly with MIR4318, and it is not classified as a canonical "therapeutic target" like receptors or enzymes. Current research considers MIR4318 one of several microRNAs with potential utility as a circulating biomarker to aid in cancer diagnostics and monitoring[3].
No drugs directly targeting MIR4318; general miRNA mechanisms include RNA silencing and mRNA degradation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4318 (MIR4318).